2023 Expert Speakers

2023 Speakers

Explore the line up of 100+ speakers and returning key opinion leaders, who presented at the 2023
3rd mRNA-Based Therapeutics Summit.

PHARMA & INDUSTRY LEADERS

ACADEMIC LEADERS

LEADING SOLUTION PARTNERS

PHARMA, BIOTECH & INDUSTRY LEADERS

Basim Hilal

Vice President - Global Regulatory Affairs, Chemistry, Manufacturing, & Controls

BioNTech US

Michiel Lodder

Chief Executive Officer

20Med Therapeutics

Walter Schmidt

Director – mRNA Division

ADvantage Therapeutics

Petro Terblanche

Managing Director

Afrigen Biologics

Amin Khan

Chief Science Advisor

Afrigen Biologics

Daryl Drummond

CSO & Co-Founder

Akagera Medicines

Annette Bak

Head of Advanced Drug Delivery

AstraZeneca

Peter Marks

Director - Center for Biologics Evaluation & Research

US Food & Drug Administration (FDA)

Mohamed ElSayed

EVP & CTO

RVAC Medicines

Guilhem Richard

CTO

EpiVax Therapeutics

Andreas Kuhn

SVP – RNA Biochemistry & Manufacturing

BioNTech SE

Pawel Widomski

Senior Director - Global Regulatory Affairs CMC

BioNTech SE

Yushi Feng

VP – Regulatory Affairs

Capricor Therapeutics

Michael Wenger

Vice President - Clinical Development

BioNTech SE

June Kim

CMC Lead

CEPI

Li Li

Principal Scientist

Merck & Co

Sonia Golombek

Senior R&D Manager

Elastrin Therapeutics

PD Dr. Carsten Rudolph

Managing Director & Chief Executive Officer

Ethris GmbH

Marco Cavaleri

Head of Biological Health Threats & Vaccine Strategy

European Medicines Agency

Gregory Fiore

Member Board of Directors

Exacis Biotherapeutics

Lusheng Fan

Investigator

GeneLeap Biotech

Elaine Peters

Director – Analytical – Individualized Cell & Gene Therapies

Genentech

Matthew Hawryluk

Executive VP & CBO

Gritstone Bio

YUSUF ERKUL

Co-founder & Chief Executive Officer

Kernal Biologics Inc.

Manfred Kraus

VP – R&D

Kernal Bio

Francis Poulin

Vice President - Ribonucleic Acid Science & Analytical Development

Laronde

Sonia Stoszek

Executive Director & Program Lead – RSV Vaccines

Moderna

Antonella Lozito

Executive Director, Infectious Disease, Global Regulatory Strategy

Moderna

Curtis Dobrowolski

Co-Founder

Nava Therapeutics

Bill Grier

Associate Director – Drug Substance Process Development

Omega Therapeutics

Gilles Besin

Chief Scientific Officer

Orbital Therapeutics

Daniel Tondera

Head of Biology

Pantherna Therapeutics

John Androsavich

Head of Global Ribonucleic Acid & Emerging Science Lead

Pfizer

Helen McCarthy

Chief Executive Officer

Phion Therapeutics Limited

Aleksandra Pastrak

CMO

Providence Therapeutics

Jason Zhang

Chief Scientific Officer & Co-Founder

RVAC

Vira Bitko

VP & Head of Vaccines

RVAC Medicines

Arunan Kaliyaperumal

VP – Preclinical Biology

ReCode Therapeutics

Daniella Ishimaru

Principal Scientist,

ReCode Therapeutics

Kathir Muthusamy

Associate Director

Regeneron Pharmaceuticals

Yue Fu

Staff Scientist

Regeneron Pharmaceuticals Inc

John Ramunas

CEO

Rejuvenation Technologies

Nathaniel Wang

CEO & Co-Founder

Replicate Bioscience

Kathleen Francissen

Global Head of Regulatory PT Cell & Gene Therapies

Roche

Benjamin Benchand

Frank DeRosa

Chief Technology Officer & Global Head of Research, Biomarkers & Messenger Ribonucleic Acid, Center of Excellence

Sanofi

Gregory Troiano

Head of cGMP Strategic Supply & Operations - mRNA Center of Excellence

Sanofi

Joshua DiNapoli

Global Project Head - mRNA Platform Development

Sanofi

Jianmei Kochling

Senior Director – Analytical Development - mRNA Center of Excellence

Sanofi

Vikram Agarwal

Head of mRNA Platform Design Data Science - mRNA Center of Excellence

Sanofi

Pierre Cote

Head of Strategic Partnership & Innovation Management

Sanofi

Nicholas Manzo

Director – CMC RNA Vaccines

Seqirus

Mohammad Safari

Head of Analytical Biochemistry

Seqirus Inc.

Dahyana Arias Escayola

Senior Scientist of Ribonucleic Acid Discovery Biology

Strand Therapeutics Inc.

Apiwat Wangweerawong

Associate Director - Lipid Nanoparticle Chemistry

Tessera Therapeutics

Jasdave Chahal

Co-Founder and Chief Scientist

Tiba Biotech LLC

Mike Zimmer

Director - Rare Diseases; Rare Research & Preclinical Development

Moderna

Aditi Mehta

Associate Director; Head of mRNA Process & Delivery

MilliporeSigma

Diane McCarthy

Senior Director, Global Biologics

U.S. Pharmacopeia

Joshua Bell

Senior Director - Enterprise Strategy

Tempus

Cory Smith

Senior Product Manager - Nucleic Acid Services

TriLink BioTechnologies

Romain Micol

President, Co-Founder & CEO

Combined Therapeutics

Matthew Duvernay

Director - Research

Cartesian Therapeutics

Jing Zhu

Vice President - Nucleic Acid & Viral Vector Technology

ReciBioPharm

Shefal Parikh

Director - mRNA Process Development

Beam Therapeutics

Dan Shores

Partner

Rothwell Figg

Rachel Groppo

Director - Replicon Team Leader

Johnson & Johnson

Alexander Zehnder

CEO

CureVac

Mari Takasaki

Manager of Research and Development

aceRNA Technologies

ACADEMIC LEADERS

Philip John Santangelo

Assistant Professor

Emory University School of Medicine

Toni Celià-Terrassa

Principal Investigator

Hospital del Mar Medical Research Institute (IMIM)

Prashant Yadav

Professor & Senior Fellow

INSEAD & Centre for Global Development

Heinrich Haas

Vice President RNA Formulation & Drug Delivery

Johannes Gutenberg-Universität Mainz

Xiaoyuan (Shawn) Chen

Professor

National University of Singapore

Gal Cafri

Immunotherapy & Genetic Engineering Group Leader

Sheba Medical Center

Becki Yi Kuang

Assistant Professor,

The Hong Kong University of Science & Technology

Anna Blakney

Assistant Professor

University of British Columbia

Simone Spuler

Professor; Co-founder

Max Delbrück Center for Molecular Medicine & Charité – Universitätsmedizin Berlin; MyoPax

Chantal Pichon

Professor

University of Orleans

BOWEN LI

Assistant Professor & Chair Of Ribonucleic Acid Vaccines & Therapeutics Research

University of Toronto

LEADING SOLUTION PARTNERS

Jon Cooper

Senior Director of mRNA Sciences & Analytical Development

Aldevron

Diana Marcantonio

Director - Biology

Applied BioMath

Ioana Panait

Research Analyst

Beacon Intelligence

Scott Alderucci

Director - mRNA Process Development & GMP

Curia Global

David Sokolowski

Nucleic Acid Therapeutics & Global Workflow Manager

Cytiva

Marco Blanchette

VP - R&D

Eclipse Bioinnovations

Jiancun (Larry) Zhang

CEO

Guangzhou Henovcom Biosciences

Senthil Ramaswamy

Executive Director - R&D, CGT

Lonza

Aleš Štrancar

Executive Managing Director

Sartorius BIA Separations

Sudhakar Voruganti

Business Development Director

Pfanstiehl

Aaron Larsen

Senior Director & Technical Head - Nucleic Acid Franchise

Resilience Inc

Eunseo (Ency) Lee

Lead Specialist

Samsung Biologics

Aditi Mehta

Associate Director; Head of mRNA Process & Delivery

MilliporeSigma

Joshua Bell

Senior Director - Enterprise Strategy

Tempus

Matthew Stone

Advanced Workflow Specialist

Sciex

Darwin Asa

Marketing manager

Thermo Fisher Scientific Inc.

Cory Smith

Senior Product Manager - Nucleic Acid Services

TriLink BioTechnologies

Jason Coleman

Clinical Application Scientist Lead

Precision NanoSystems

Richard Sayre

CSO

Mercury Bio

Jordana Henderson

Associate Director - mRNA Research & Development

TriLink Biotechnologies

Jing Zhu

Vice President - Nucleic Acid & Viral Vector Technology

ReciBioPharm

Bruce Baretz Ph.D

President

Lipoid

Phil Challis

VP - Product Development

eTheRNA Immunotherapies

Ann Gidner

CEO

Ziccum

John Patton

Head of Scientific Advisory Board

Kindeva Drug Delivery